Evaluating Temporary Artery Clipping During Robotically-Assisted Myomectomy for Uterine Fibroids in Women Aged 18 to 50

What this Trial Is About

Researchers are evaluating the effectiveness of temporarily clipping the uterine artery and utero-ovarian ligament during robotically assisted myomectomy RAM for women with uterine fibroids. Uterine fibroids are common non-cancerous tumors that can cause heavy bleeding, pain, or infertility. While RAM is increasingly used for fibroid removal, controlling bleeding during surgery remains challenging. This randomized controlled trial aims to assess blood loss, need for transfusion, and hemoglobin changes, along with complications and operation time. The study compares two groups one receiving temporary clipping of the uterine arteries and utero-ovarian ligaments using laparoscopic clips during RAM, and the other undergoing RAM without this clipping. The procedure involves temporarily blocking blood flow to reduce bleeding. Both groups undergo robotically assisted myomectomies, and the clipping technique has been studied previously in conventional laparoscopy but not yet in RAM. Participants will be monitored for blood loss during surgery, hemoglobin levels, and any need for blood transfusions within one week. Secondary assessments include operation duration, hospital stay length, complication rates, postoperative pain, and use of additional bleeding control methods. The total follow-up includes monitoring for complications up to six weeks after surgery, ensuring detailed evaluation of safety and surgical outcomes.

Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled Trial